Germany
Japan
United Kingdom
China
Primary Antibodies
Download
Rabbit anti-CFB Polyclonal Antibody
| Applications | ICC/IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human CFB |
Rabbit anti-PRG2 Polyclonal Antibody
| Applications | ICC/IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human PRG2 |
TGFBI Goat Polyclonal (Internal) Antibody
| Applications | IHC |
| Reactivities | Bat, Gibbon, Bovine, Dog, Gorilla, Horse, Human, Mouse, Pig, Rabbit, Rat |
| Conjugation | Unconjugated |
| Immunogen | TGFBI antibody was raised against synthetic peptide C-QLYTDRTEKLRPE from an internal region of human TGFBI (NP_000349.1). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Mouse, Rat, Elephant, Panda, Bovine, Dog, Bat, Horse, Rabbit, Pig, Opossum (100%); Marmoset, Platypus (92%). |
Rabbit Polyclonal antibody to WNT11 (wingless-type MMTV integration site family, member 11)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 1 and 310 of WNT11 (Uniprot ID#O96014) |
Rabbit polyclonal WNT5B Antibody (Center)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This WNT5B antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 153-182 amino acids from the Central region of human WNT5B. |
Rabbit anti-EPO Polyclonal Antibody
| Applications | ICC/IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human EPO |
Rabbit anti-TFRC Polyclonal Antibody
| Applications | ICC/IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human TFRC |
Rabbit Polyclonal NPTX2 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | NPTX2 antibody was raised against a 16 amino acid synthetic peptide near the center of the human NPTX2. The immunogen is located within amino acids 170 - 220 of NPTX2. |
Rabbit polyclonal PCSK2 Antibody (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This PCSK2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 87-116 amino acids from the N-terminal region of human PCSK2. |
Rabbit anti-IGF2 Polyclonal Antibody
| Applications | ICC/IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human IGF2 |
Rabbit anti-TNFSF13B Polyclonal Antibody
| Applications | ICC/IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human TNFSF13B |
Rabbit polyclonal antibody to Factor XIIIa (coagulation factor XIII, A1 polypeptide)
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 1 and 258 of Factor XIIIa (Uniprot ID#P00488) |
Rabbit polyclonal PEK/PERK (Thr981) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PEK/PERK around the phosphorylation site of threonine 981 (R-H-TP-G-Q). |
| Modifications | Phospho-specific |
Rabbit Polyclonal AFP Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | AFP antibody was raised against a 14 amino acid synthetic peptide near the amino terminus of human AFP. The immunogen is located within amino acids 340 - 390 of AFP. |
ABO Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human ABO |
Active filters
Reactivities
- Rat
Applications
- IHC
Families
- Secreted Protein
Filter by
Target Symbol
- LOX (52)
- AGR2 (45)
- F13A1 (45)
- SYP (38)
- EGFR (31)
- SYT4 (27)
- SIL1 (25)
- TIMP2 (23)
- CPA2 (21)
- WNT3 (21)
- ERBB3 (19)
- FN1 (17)
- FGFR2 (16)
- NTF3 (16)
- NOG (15)
- RNPEP (15)
- IGF1 (12)
- LOXL2 (12)
- VEGFB (12)
- RSPO1 (11)
- RSPO3 (11)
- PMEL (10)
- POSTN (10)
- SFRP2 (10)
- ANGPT1 (8)
- ANGPT2 (8)
- TGFBI (7)
- BDNF (6)
- FGF2 (6)
- GCG (6)
- NTF4 (6)
- VEGFC (6)
- ADAMTS4 (5)
- BMP4 (5)
- CANT1 (5)
- DPP4 (5)
- FGF13 (5)
- FGG (5)
- IL17B (5)
- LAMA4 (5)
- LAMB2 (5)
- LGALS3 (5)
- RAB37 (5)
- SERPINB3 (5)
- TAC1 (5)
- ADM (4)
- AFP (4)
- CALR (4)
- DEFA1 (4)
- EIF2AK3 (4)
- GNAS (4)
- SPP1 (4)
- ACE2 (3)
- ADAMTS5 (3)
- ADIPOQ (3)
- AGT (3)
- ANGPTL4 (3)
- BMP3 (3)
- CCL17 (3)
- CCL2 (3)
- EDA (3)
- EPOR (3)
- IL20 (3)
- INHBA (3)
- INS (3)
- KL (3)
- LEP (3)
- LY96 (3)
- MANF (3)
- MUC1 (3)
- PLXDC1 (3)
- SERPINA1 (3)
- SERPINA3 (3)
- SHBG (3)
- SHH (3)
- SPATA6 (3)
- TFF3 (3)
- TGFB1 (3)
- TNC (3)
- TNF (3)
- TNFRSF11B (3)
- TTR (3)
- VEGFA (3)
- VGF (3)
- WNT10A (3)
- ABO (2)
- ADAMDEC1 (2)
- ADAMTSL1 (2)
- ADCK1 (2)
- AGR3 (2)
- AGRP (2)
- AMBP (2)
- AMH (2)
- AMPH (2)
- ANGPTL3 (2)
- ANXA2 (2)
- APOA1 (2)
- APOH (2)
- ARSK (2)
- B2M (2)
Antibody Hosts
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (196)
- Cytokine-cytokine receptor interaction (138)
- MAPK signaling pathway (114)
- Focal adhesion (109)
- Regulation of actin cytoskeleton (91)
- Complement and coagulation cascades (78)
- Endocytosis (70)
- Prostate cancer (65)
- Melanoma (64)
- Pancreatic cancer (63)
- Bladder cancer (56)
- Calcium signaling pathway (54)
- ErbB signaling pathway (53)
- Wnt signaling pathway (52)
- Hedgehog signaling pathway (48)
- Basal cell carcinoma (47)
- Glioma (45)
- TGF-beta signaling pathway (44)
- ECM-receptor interaction (43)
- Melanogenesis (43)
- Colorectal cancer (38)
- mTOR signaling pathway (38)
- GnRH signaling pathway (37)
- Gap junction (35)
- Non-small cell lung cancer (33)
- Renal cell carcinoma (32)
- Adherens junction (31)
- Dorso-ventral axis formation (31)
- Endometrial cancer (31)
- Epithelial cell signaling in Helicobacter pylori infection (31)
- Neurotrophin signaling pathway (31)
- Small cell lung cancer (29)
- Dilated cardiomyopathy (26)
- Jak-STAT signaling pathway (26)
- Hypertrophic cardiomyopathy (HCM) (23)
- p53 signaling pathway (20)
- Adipocytokine signaling pathway (17)
- Hematopoietic cell lineage (17)
- Long-term depression (17)
- Oocyte meiosis (15)
- Progesterone-mediated oocyte maturation (15)
- Chemokine signaling pathway (14)
- Toll-like receptor signaling pathway (14)
- Alzheimer's disease (13)
- Neuroactive ligand-receptor interaction (13)
- Apoptosis (12)
- NOD-like receptor signaling pathway (11)
- PPAR signaling pathway (11)
- Type I diabetes mellitus (11)
- Cell cycle (9)
- Type II diabetes mellitus (9)
- Axon guidance (8)
- Antigen processing and presentation (7)
- Chronic myeloid leukemia (7)
- Graft-versus-host disease (7)
- Metabolic pathways (7)
- Renin-angiotensin system (7)
- Allograft rejection (6)
- Amyotrophic lateral sclerosis (ALS) (6)
- Huntington's disease (6)
- Purine metabolism (6)
- Pyrimidine metabolism (6)
- Systemic lupus erythematosus (6)
- Asthma (5)
- Natural killer cell mediated cytotoxicity (5)
- Cytosolic DNA-sensing pathway (4)
- Fc gamma R-mediated phagocytosis (4)
- Maturity onset diabetes of the young (4)
- Prion diseases (4)
- SNARE interactions in vesicular transport (4)
- T cell receptor signaling pathway (4)
- Taste transduction (4)
- Vascular smooth muscle contraction (4)
- Vibrio cholerae infection (4)
- Autoimmune thyroid disease (3)
- Fc epsilon RI signaling pathway (3)
- Insulin signaling pathway (3)
- Pathogenic Escherichia coli infection (3)
- RIG-I-like receptor signaling pathway (3)
- Regulation of autophagy (3)
- VEGF signaling pathway (3)
- Cell adhesion molecules (CAMs) (2)
- Glycosphingolipid biosynthesis - lacto and neolacto series (2)
- Leukocyte transendothelial migration (2)
- Primary immunodeficiency (2)
- Acute myeloid leukemia (1)
- Ether lipid metabolism (1)
- Glycosaminoglycan degradation (1)
- Histidine metabolism (1)
- N-Glycan biosynthesis (1)
- Viral myocarditis (1)
- beta-Alanine metabolism (1)